SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-058049
Filing Date
2020-03-02
Accepted
2020-03-02 08:44:33
Documents
2
Period of Report
2020-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888152d8k.htm 8-K 17745
2 EX-99.1 d888152dex991.htm EX-99.1 81315
  Complete submission text file 0001193125-20-058049.txt   100246
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 20674320
SIC: 2834 Pharmaceutical Preparations